Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 29, 2016
- Revision received October 18, 2016
- Accepted October 24, 2016
- Published online December 5, 2016.
Copyright & Usage
Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- BRYAN M. HANCOCK1,
- KATHLEEN L. MCGUIRE1,
- SHINGO TSUJI2,
- KATHERINE REIL2,
- VERONICA HERNANDEZ2,
- MATTHEW J. GIACALONE2 and
- W. T. GODBEY3⇑
- 1Department of Cell & Molecular Biology, San Diego State University, San Diego, CA, U.S.A.
- 2Vaxiion Therapeutics, San Diego, CA, U.S.A.
- 3Department of Chemical and Biological Engineering, Tulane University, New Orleans, LA, U.S.A.
- Correspondence to: W.T. Godbey, Department of Chemical and Biological Engineering, 6823 St. Charles Ave., 300 Lindy Boggs Center, New Orleans, LA 70118, U.S.A. E-mail: Godbey{at}Tulane.edu
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Intralesional administration of VAX014 facilitates in situ immunization and potentiates immune checkpoint blockade in immunologically cold tumors
- Report on the NCI Microbial-Based Cancer Therapy Conference
- A New Prognostic Tool for Patients Undergoing Radiotherapy plus Upfront Transurethral Resection for Bladder Cancer
- Simplified Comorbidity Score and Eastern Cooperative Oncology Group Performance Score Predicts Survival in Patients Receiving Organ-preserving Treatment for Bladder Cancer